Navigation Links
Peptidomimetic in Medical News

Synthetech Announces Fiscal 2009 Results

...mpliance with U.S. Food and Drug Administration ( FDA ) regulations. Our products support the development and manufacture of therapeutic peptides and peptidomimetic (peptide-like) small molecule drugs from early stages of a customer's clinical development through market launch and into commercial production. Synt...

Synthetech Earns National Recognition for Performance Improvement Program

...specialty resins, primarily for the pharmaceutical industry. Synthetech's products support the development and manufacture of therapeutic peptides and peptidomimetic small molecule drugs at every stage of a customer's clinical development pipeline, and are used in drugs for the treatment of AIDS, cancer, cardiovasc...

Synthetech Reports Second Quarter Fiscal 2009 Results

... compliance with U.S. Food and Drug Administration (FDA) regulations. Our products support the development and manufacture of therapeutic peptides and peptidomimetic (peptide-like) small molecule drugs from early stages of a customer's clinical development through market launch and into commercial production. Synth...
Peptidomimetic in Medical Technology

Lytix Presents LTX-109 Anti-Microbial Data at ICAAC

...nnounced results of studies on its lead antimicrobial candidate LTX-109. Presented at ICAAC in Washington, DC, the studies showed that the novel lytic peptidomimetic has an ultra-rapid bacteriocidal effect, significantly better towards killing Staphylococcus aureus and Streptococcus pyogenes than marketed gold stan...

Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure

...tic peptide (ANP) is a naturally produced peptide hormone involved in regulation of water and sodium levels in the circulation. Palatin's PL-3994 is a peptidomimetic compound, which incorporates features of both natural ANP and small molecules. Preclinical studies have demonstrated that PL-3994 is highly potent. I...
Peptidomimetic in Biological News

Novel therapy combinations gain ground in treating hepatitis

...f] Scientists are reviewing new compounds in combination with current standard hepatitis therapies to produce better patient outcomes. A new oral peptidomimetic protease inhibitor, VX-950, has previously shown substantial anti-viral effects in combination with the frequently used hepatitis therapy pegylated in...
Peptidomimetic in Biological Technology

Synthetech Reports First Quarter Fiscal 2010 Results

...mpliance with U.S. Food and Drug Administration ( FDA ) regulations. Our products support the development and manufacture of therapeutic peptides and peptidomimetic (peptide-like) small molecule drugs from early stages of a customer's clinical development through market launch and into commercial production. Synt...

First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418

...started in a Phase I clinical trial of GGTI-2418. GGTI-2418 is a synthetic peptidomimetic inhibitor of geranylgeranyltransferase I (GGTase I) that induces apoptosis ...inventors of GGTI-2418. About GGTI-2418 GGTI-2418 is a synthetic peptidomimetic inhibitor of GGTase I that appears to induce apoptosis by downregulating se...

FDA Accepts Investigational New Drug (IND) Application for Tigris Pharmaceutical's GGTI-2418

...ety of GGTI-2418 during the first quarter of 2009. GGTI-2418 is a synthetic peptidomimetic inhibitor of geranylgeranyltransferase I (GGTase I) that induces apoptosis ...ity of South Florida . About GGTI-2418 GGTI-2418 is a synthetic peptidomimetic inhibitor of GGTase I that appears to induce apoptosis by downregulating se...

Tigris Pharmaceuticals Files IND Application for GGTI-2418

...(FDA) for GGTI-2418, a novel anticancer compound. GGTI-2418 is a synthetic peptidomimetic inhibitor of geranylgeranyltransferase I (GGTase I) that appears to induce ...ersity of South Florida . About GGTI-2418 GGTI-2418 is a synthetic peptidomimetic inhibitor of geranylgeranyltransferase I (GGTase I) that appears to induce ...
Peptidomimetic in Biological Products

Custom Peptidomimetic Microarray from LC Sciences

Description: Peptide microarrays containing peptidomimetics built on the flexible and powerful Paraflo microfluidic on-chip synthesis platform. These microarrays are available as part of our comprehensive Custom Peptide Microarray Service. Custom Probe Content Probe content is completely customer specified. ...
Company:LC Sciences
Other Tags
(Date:5/21/2013)... 2013) A paper recently published in the ... physicians and scientists at the University of Colorado School ... for pulmonary fibrosis can be used to identify individuals ... looked at a fairly common variant of the gene ... the mucous produced by the bronchial tubes. While this ...
(Date:5/21/2013)... adenoids and tonsils, is performed 500,000 times a year ... children with obstructive sleep apnea. However, the procedure,s ... behavior, sleep apnea symptoms, and quality of life has ... led by Susan Redline, MD, MPH, director of ... Clinic Director of the Division of Sleep Medicine at ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Two executives ... Guidance (SBG) will identify which strategies can be most ... high-quality care to the members who are taking them, ... Services, Inc., “How to Manage Specialty Drugs to ... pharmaceuticals are now the main driver for rising prescription ...
(Date:5/21/2013)... 22, 2013 About one in six ... Fertility Clinics industry one of the fastest growing ... who are unable to conceive naturally through a variety ... which is in-vitro fertilisation (IVF) cycles. Over the past ... Australia has increased by 4.4% per annum to a ...
(Date:5/21/2013)... PHILADELPHIA ─ A study of veterans at high risk ... (LDCT) can be highly effective in helping clinicians spot ... patients, may indicate the earliest stages of the disease. ... of a conventional CT scan. , Results of the ... Conference. , "Lung cancer is the leading cause of ...
Breaking Medicine News(10 mins):Health News:Researchers find genetic risk factor for pulmonary fibrosis 2Health News:Early removal of adenoids and tonsils can help pediatric sleep apnea symptoms 2Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Low radiation scans help identify cancer in earliest stages 2Health News:Low radiation scans help identify cancer in earliest stages 3
(Date:5/21/2013)... largest scientific society, invites news media coverage of ... 2013, in Indianapolis, Ind. It will take place ... hotels. , With more than 7,100 presentations on ... astronomy to zoology ― the meeting will offer ... of spot news and feature possibilities. The topics ...
(Date:5/21/2013)... , Where? Copenhagen, Denmark: Bella Center ... 2013 , Why? An annual ... policy developments, manufacturing and installation, drawing on leading experiences ... 2013 edition from a record of more than 900 ... 240 plenary and oral presentations, more than 460 visual ...
(Date:5/21/2013)... 2013 Royal Philips Electronics (NYSE: PHG, AEX: ... portable ultrasound with Philips, industry leading Live 3D TEE, ... xMATRIX with available Live 3D TEE and ICE will ... the EuroPCR, official meeting for the European Association of ... its launch in 2012, Philips CX50 xMATRIX has been ...
Breaking Biology News(10 mins):21st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
Other Contents